DeSantis gifts $2 million to AI-focused biotech co-founded by FIU researcher

Full Article
DeSantis gifts $2 million to AI-focused biotech co-founded by FIU researcher

First Ascent Biomedical, a Miami-based biotech company, has secured a $2 million grant from the Florida Cancer Innovation Fund. This funding aims to enhance the development of personalized cancer treatments specifically for underserved communities. The company utilizes artificial intelligence and genetic testing to create tailored treatment plans for patients.

Co-founded by Dr. Diana Azzam from Florida International University, First Ascent Biomedical combines drug testing with AI-guided tumor mapping. The grant will help generate clinical data necessary for FDA approval of its innovative treatment planning technologies. This initiative reflects Florida's commitment to pioneering healthcare solutions that can be replicated in other states.

• First Ascent Biomedical receives $2 million for AI-driven cancer treatment development.

• AI and genetic testing are used for personalized cancer treatment plans.

Key AI Terms Mentioned in this Article

Artificial Intelligence

AI is utilized to analyze tumor weaknesses and develop personalized treatment plans.

Genetic Testing

Genetic testing is combined with drug testing to tailor cancer treatments to individual patients.

Tumor Mapping

AI-guided tumor mapping identifies vulnerabilities in cancer cells to optimize treatment strategies.

Companies Mentioned in this Article

First Ascent Biomedical

First Ascent Biomedical focuses on personalized cancer treatments using AI and genetic testing.

Florida International University

FIU collaborates with First Ascent to advance cancer research and treatment innovations.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 4month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 4month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 4month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 4month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics